martes, 20 de agosto de 2024

FDA approves lazertinib with amivantamab-vmjw for non-small lung cancer

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lazertinib-amivantamab-vmjw-non-small-lung-cancer?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario